Functional alterations of liver innate immunity of mice with aging in response to CpG-oligodeoxynucleotide

Hepatology

Volumn 48, Issue 5, 2008, Pages 1586-1597

  Kawabata, Toshinobu ^a   Kinoshita, Manabu ^a   Inatsu, Akihito ^a   Habu, Yoshiko ^a   Nakashima, Hiroyuki ^a   Shinomiya, Nariyoshi ^a   Seki, Shuhji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BACTERIAL DNA; CPG OLIGODEOXYNUCLEOTIDE; FAS LIGAND; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GANGLIOTETRAOSYLCERAMIDE; PERFORIN; PROTEIN ANTIBODY; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; FASL PROTEIN, MOUSE; OLIGODEOXYRIBONUCLEOTIDE;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL AGING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; INNATE IMMUNITY; KNOCKOUT MOUSE; KUPFFER CELL; LEUKOCYTE FUNCTION; LIVER INJURY; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; ANIMAL; C57BL MOUSE; CYTOLOGY; FLOW CYTOMETRY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LIVER; MOUSE MUTANT; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PRENATAL DEVELOPMENT;

AGING; ANIMALS; BASE SEQUENCE; FAS LIGAND PROTEIN; FLOW CYTOMETRY; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGODEOXYRIBONUCLEOTIDES; PERFORIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56149117581     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22489     Document Type: Article

References (40)

1. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-549.
2. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709-760.
3. Razin A, Friedman J. DNA methylation and its possible biological roles. Prog Nucleic Acid Res Mol Biol 1981;25:33-52.
4. Roman M, Martin-Orozco E, Goodman JS, Nguyen MD, Sato Y, Ronaghy A, et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997;3:849-854.
5. Medzhitov R, Janeway CA Jr. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997;91:295-298.
6. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998;282:2085-2088.
7. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745.
8. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol 1999;162:2291-2298.
9. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Rocken M, Wagner H, et al.CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 1998;160:3627-3630.
10. Ishii KJ, Kawakami K, Gursel I, Conover J, Joshi BH, Klinman DM, et al. Antitumor therapy with bacterial DNA and toxin: Complete regression of established tumor induced by liposomal CpG oligodeoxynucleotides plus interleukin-13 cytotoxin. Clin Cancer Res 2003;9:6516-6522.
11. Mason KA, Ariga H, Neal R, Valdecanas D, Hunter N, Krieg AM, et al. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. Clin Cancer Res 2005;11: 361-369.
12. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330:662-664.
13. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med 1987;38:417-432.
14. Hashimoto W, Takeda K, Anzai R, Ogasawara K, Sakihara H, Sugiura K, et al. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
15. Takeda K, Seki S, Ogasawara K, Anzai R, Hashimoto W, Sugiura K, et al. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996; 156:3366-3373.
16. Seki S, Hashimoto W, Ogasawara K, Satoh M, Watanabe H, Habu Y, et al. Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice. Immunology 1997;92:561-566.
17. Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, Seki S. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment. Immunology 2004;113:35-43.
18. Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol 2001;166: 6578-6584.
19. Inui T, Nakagawa R, Ohkura S, Habu Y, Koike Y, Motoki K, et al. Age-associated augmentation of the synthetic ligand-mediated function of mouse NK1.1 ag(+) T cells: Their cytokine production and hepatotoxicity in vivo and in vitro. J Immunol 2002;169:6127-6132.
20. Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna-Romero O, Nakayama T, Taniguchi M, et al. alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci U S A 2000;97:8461-8466.
21. Sato K, Kinoshita M, Motegi A, Habu Y, Takayama E, Nonoyama S, Hiraide H, et al. Critical role of the liver CD8+ CD122+ T cells in the generalized Shwartzman reaction of mice. Eur J Immunol 2005;35:593-602.
22. Motegi A, Kinoshita M, Sato K, Shinomiya N, Ono S, Nonoyama S, et al. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells. J Leukoc Biol 2006;79:463-472.
23. Inui T, Nakashima H, Habu Y, Nakagawa R, Fukasawa M, Kinoshita M, et al. Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice. J Hepatol 2005;43:670-678.
24. Nakashima H, Inui T, Habu Y, Kinoshita M, Nagao S, Kawaguchi A, et al. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Gastroenterology 2006;131:1573-1583.
25. Sparwasser T, Miethke T, Lipford G, Borschert K, Hacker H, Heeg K, et al. Bacterial DNA causes septic shock. Nature 1997;386:336-337.
26. Cowdery JS, Chace JH, Yi AK, Krieg AM. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996;156:4570-4575.
27. Kinoshita M, Uchida T, Nakashima H, Ono S, Seki S, Hiraide H. Opposite effects of enhanced tumor necrosis factor-alpha production from Kupffer cells by gadolinium chloride on liver injury/mortality in endotoxemia of normal and partially hepatectomized mice. Shock 2005;23:65-72.
28. Seki S, Osada S, Ono S, Aosasa S, Habu Y, Nishikage T, et al. Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice. Infect Immun 1998;66:5286-5294.
29. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13:151-153.
30. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001;104:487-501.
31. Fang L, Fang J, Chen CQ. TNF receptor-associated factor-2 binding site is involved in TNFR75-dependent enhancement of TNFR55-induced cell death. Cell Res 2001;11:217-222.
32. Schlosser SF, Azzaroli F, Dao T, Hingorani R, Nicholas Crispe I, Boyer JL. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/ APO-1)-ligand: Characterization of an in vitro system. HEPATOLOGY 2000; 32:779-785.
33. Heumann D, Le Roy D, Zanetti G, Eugster HP, Ryffel B, Hahne M, et al. Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis. J Inflamm 1995;47:173-179.
34. Halpern MD, Kurlander RJ, Pisetsky DS. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell Immunol 1996;167:72-78.
35. Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:1840-1845.
36. Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T, et al. Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res 2001;61:5523-5528.
37. Kaser A, Enrich B, Ludwiczek O, Vogel W, Tilg H. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway. Clin Exp Immunol 1999;118:71-77.
38. Fujio H, Kawamura I, Miyamoto H, Mitsuyama M, Yoshida S. Decreased capacity of aged mice to produce interferon-gamma in Legionella pneumophila infection. Mech Ageing Dev 1995;81:97-106.
39. Rutkute K, Karakashian AA, Giltiay NV, Dobierzewska A, Nikolova-Karakashian MN. Aging in rat causes hepatic hyperresposiveness to interleukin-1beta which is mediated by neutral sphingomyelinase-2. HEPATOLOGY 2007;46:1166-1176.
40. Yamamoto K, Shimokawa T, Yi H, Isobe K, Kojima T, Loskutoff DJ, et al. Aging accelerates endotoxin-induced thrombosis: Increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am J Pathol 2002;161:1805-1814.